Trueblue
TBI
172 hedge funds and large institutions have $605M invested in Trueblue in 2022 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 70 increasing their positions, 60 reducing their positions, and 19 closing their positions.
17% more repeat investments, than reductions
Existing positions increased: 70 | Existing positions reduced: 60
5% more capital invested
Capital invested by funds: $576M → $605M (+$29.6M)
0.37% more ownership
Funds ownership: 96.68% → 97.06% (+0.37%)
0% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 19
1% less funds holding
Funds holding: 173 → 172 (-1)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $91K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Pzena Investment Management
New York
|
+$8.78M |
| 2 |
Morgan Stanley
New York
|
+$3.69M |
| 3 |
AQR Capital Management
Greenwich,
Connecticut
|
+$1.8M |
| 4 |
First Trust Advisors
Wheaton,
Illinois
|
+$1.74M |
| 5 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$1.55M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ICM
Invenomic Capital Management
Boston,
Massachusetts
|
-$6.22M |
| 2 |
MFIMFI
Mesirow Financial Investment Management - Fixed Income
Chicago,
Illinois
|
-$4.54M |
| 3 |
Norges Bank
Oslo,
Norway
|
-$3.37M |
| 4 |
Renaissance Technologies
New York
|
-$2.7M |
| 5 |
BlackRock
New York
|
-$2.43M |
TBI Hedge Fund Activity: Q3 2022 in Review
172 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Trueblue (TBI) for Q3 2022, worth a combined $605M — up 5.1% from $576M a quarter earlier.
Fund positioning in TBI was balanced in Q3 2022: 19 funds opened new positions, 19 closed out, 70 added to existing stakes and 60 trimmed.
The largest buyer was Pzena Investment Management, adding an estimated $8.78M. The largest seller was Invenomic Capital Management, exiting entirely with an estimated $6.22M sold.
- 172 institutional investors held Trueblue (TBI) as of Q3 2022, down from 173 in Q2 2022.
- Funds reported $605M of Trueblue stock for Q3 2022, up 5.1% quarter-over-quarter.
- 19 funds opened new Trueblue positions in Q3 2022 and 19 closed out, a net change of 0 holders.
- The largest Trueblue buyer in Q3 2022 was Pzena Investment Management, an estimated $8.78M added.
- The largest Trueblue seller in Q3 2022 was Invenomic Capital Management, an estimated $6.22M sold.
Based on aggregated 13F filings for Q3 2022.